Sunday, March 20, 2016

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.

Emphysema. Chronic obstructive pulmonary disease. diagram showing a cross-section of normal lung and lungs damaged by COPD. Human anatomy

Chronic obstructive pulmonary disease (COPD) is an irreversible disease, diagnosed predominantly in smokers. COPD is currently the third leading cause of death worldwide. Far more than 15 % of smokers get COPD: in fact, most develop some amount of pulmonary impairment. Smoking-related COPD is associated with both acute exacerbations and is closely correlated to comorbidities, such as cardiovascular disease and lung cancer. The objective of this study (KOL-Örestad) was to identify biomarkers in smokers and ex-smokers, with early signs of COPD, and compare these biomarkers with those of non-smokers and healthy smokers/ex-smokers. The participants in the study were recruited from Örestadskliniken, a primary health care clinic in Malmö, Sweden. Two hundred smokers and ex-smokers diagnosed with COPD with airflow restriction according to GOLD stages 1-4 will be included and compared with 50 healthy never-smokers, and 50 healthy smokers/ex-smokers without airflow restriction (total n = 300). The age distribution is 35-80 years. The participants undergo a health examination including medical history, smoking history, lung function measurements, and respond to a “Quality of Life” questionnaire. Blood samples are drawn every 6 months during a period of 5 years. Additional blood sample collection is performed if participants are experiencing an exacerbation. The blood fractions will be analyzed by standard clinical chemistry assays and by proteomics utilizing mass spectrometry platforms. Optimal sample integrity is ensured by rapid handling with robotic biobank processing followed by storage at -80 °C.

The study design will enable discovery of new biomarkers by using novel mass spectrometric techniques that define early changes of COPD. Such panels of novel biomarkers may be able to distinguish COPD from closely related diseases, co-morbidities, and contribute to an increased understanding of these diseases. Graphical abstract KOL-Örestad Study.

1 comment:

  1. How can I explain this to the world that there is a man who can cure COPD, I was diagnosed for the past 9years I have being into COPD drug since then,so I decide to look for help in the internet then I found this woman post write about this great man Dr.Abumere, telling people about him that this man have cured to COPD I don’t believe that because all I have in mind is COPD had no cure,thank god for my life today am COPD negative through the power of Dr.Abumere, I contacted this man for help because who write about him drop an email of the man I pick the email and emailed him for the cure this man told me what to do about the cure well am from Philadelphia so i bought the medicine from him,he deliver it to me without wasting any time because he told me my health is so much important to him,so i receive the herbal remedies on the address given to him,so i go with the instruction given to me,truly i went for check up which the doctor told me that am fully cured he was also surprise because i told him about this great doctor tho he never believed him,I'm a great testimony of it so i assure you that once you use his herbal medicine you shall be one,you can simply email him and follow the instruction given to you. Email address :abumereherbalcentre@gmail.com
    thank you Dr i will never stop sharing you testimony

    ReplyDelete